17.81
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ERAS Giù?
Forum
Previsione
Erasca Inc Borsa (ERAS) Ultime notizie
JPMorgan and Stifel Enhance Erasca’s Market Prospects with High Price Targets - timothysykes.com
Erasca CLO Ebun Garner sells $1.3m in ERAS stock By Investing.com - Investing.com Australia
Insider Selling: Erasca (NASDAQ:ERAS) Insider Sells 80,000 Shares of Stock - MarketBeat
Erasca CLO Ebun Garner sells $1.3m in ERAS stock - Investing.com
Erasca (ERAS) Chief Legal Officer exercises options, sells 80K shares under 10b5-1 plan - Stock Titan
Erasca (NASDAQ:ERAS) Trading 8.2% HigherHere's What Happened - MarketBeat
Erasca Inc stock hits 52-week high at $14.63 - Investing.com
Erasca reports proposed 80,000-share sale (NASDAQ: ERAS) - Stock Titan
Erasca (NASDAQ:ERAS) Hits New 1-Year HighShould You Buy? - MarketBeat
Erasca Inc stock hits 52-week high at 16.41 USD - Investing.com
Erasca Inc stock hits 52-week high at 16.41 USD By Investing.com - Investing.com India
IBRX stock notches strongest quarter ever — but these 2 smaller biotech plays ran even hotter - MSN
ERAS Technical Analysis & Stock Price Forecast - Intellectia AI
Revenue Check: How does Erasca Inc perform in inflationary periods2026 Institutional & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Erasca (ERAS) price target increased by 42.72% to 14.99 - msn.com
Erasca CMO's Direct Stake Hit Zero. Her Options Position Didn't - Yahoo Finance
Erasca (NASDAQ:ERAS) Shares Up 8.8%Should You Buy? - MarketBeat
Erasca’s Stock Surges Higher Amid Pipeline Optimism - StocksToTrade
Erasca’s HERKULES-3 Trial Reaches Completion: What Investors Should Watch in ERAS-007 - TipRanks
TNGX stock hits record high on inking collaboration deal with ERAS - MSN
Erasca (ERAS) adds 13%; soars 310% YTD - MSN
Mizuho initiates Erasca (ERAS) with 'outperform' rating and $16 PT - msn.com
Assessing Erasca (ERAS) Valuation After ERAS-0015 Licensing Win And Data Anticipation - Yahoo Finance
Certain Stock Options of Erasca, Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - MarketScreener
A Look At Erasca (ERAS) Valuation After Its Strong Recent Share Price Rally - simplywall.st
How Erasca’s Expanded ERAS-0015 License and Narrower 2025 Loss Will Impact Erasca (ERAS) Investors - simplywall.st
Erasca (ERAS) Adds 13%; Soars 310% YTD - Insider Monkey
5 Stocks Dominating Today’s Market Action - Insider Monkey
Erasca (NASDAQ:ERAS) Shares Up 10.3% on Better-Than-Expected Earnings - MarketBeat
Guggenheim more than doubles Erasca (ERAS) PT following clinical progress and updated pipeline models - msn.com
ERAS Surges as JP Morgan Raises Price Target | ERAS Stock News - GuruFocus
JPMorgan Chase & Co. Increases Erasca (NASDAQ:ERAS) Price Target to $25.00 - MarketBeat
Analysts Offer Insights on Healthcare Companies: BeOne Medicines (ONC), Argenx Se (ARGX) and Erasca (ERAS) - The Globe and Mail
Erasca, Inc. (NASDAQ:ERAS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Chipmakers Recap: Should I invest in Erasca Inc before earnings2026 Valuation Update & Weekly Sector Rotation Insights - baoquankhu1.vn
Erasca Form 144: Foundation Lists Proposed Common Sales | ERAS SEC FilingForm 144 - Stock Titan
Erasca (NASDAQ:ERAS) Stock Price Expected to Rise, Guggenheim Analyst Says - MarketBeat
Erasca’s Stock Faces Pressure as CMO Offloads Shares - StocksToTrade
uniQure, Syndax and Erasca Are Drawing Analyst Interest Ahead of Key Drug Catalysts - AOL.com
Erasca’s CMO Stock Sale Raises Eyebrows Amid Market Uncertainty - timothysykes.com
FTAI Aviation To Rally More Than 43%? Here Are 10 Top Analyst Forecasts For Friday - Sahm
Assessing Tango Therapeutics (TNGX) Valuation After Vopimetostat Progress And New Erasca Collaboration - simplywall.st
Erasca secures worldwide rights to RAS-targeting drug ERAS-0015 By Investing.com - Investing.com Nigeria
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):